Zhongxing Liao MD
Professor of Radiation Oncology, University Tex Houston
Join to view full profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Liao is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 1995 - 1999
University of Kansas (Wichita)Internship, Internal Medicine, 1994 - 1995
Hunan Medical UniversityClass of 1982
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2024 - 2028
GA State Medical License 2024 - 2027
MS State Medical License 2024 - 2027
OK State Medical License 2020 - 2027
TN State Medical License 2024 - 2027
AL State Medical License 2024 - 2026
American Board of Radiology Radiation Oncology- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ClinicStation, UT MD Anderson Cancer Center, 2013-2015
- Top Doctors:SE Texas Castle Connolly, 2013
Clinical Trials
- Thermal Signature of Patients Undergoing Radiation Therapy
- 3-Dimensional Conformal Radiation Therapy Versus Intensity Modulated Radiation Therapy Start of enrollment: 2007 Aug 21
- Sorafenib and Thoracic Radiation for Patients With Non-Small Cell Lung Cancer Start of enrollment: 2008 Jan 25
Publications & Presentations
PubMed
- Deep learning of CT imaging predicts PD-L1 expression and immunotherapy response in metastatic NSCLC: A multi-center study.Amgad Muneer, Eman Showkatian, Maliazurina B Saad, Lingzhi Hong, Shenduo Li
Cancer Letters. 2026-09-28 - CT-based deep foundation model for predicting immune checkpoint inhibitor-induced pneumonitis risk in lung cancer.Amgad Muneer, Eman Showkatian, Yuliya Kitsel, Maliazurina B Saad, Sheeba J Sujit
Journal for Immunotherapy of Cancer. 2026-09-18 - Bayesian personalized dose constraints in selecting patients with non-small cell lung cancer for cardiac risk-adaptive treatment.Mei Chen, Tianlin Xu, Ting Xu, Rachel C Maguire, Xinru Chen
Radiotherapy and Oncology. 2026-09-12
Journal Articles
- The Utility of Quantitative Ct Radiomics Features for Improved Prediction of Radiation PneumonitisZhongxing Liao, MD, Medical Physics
- Does Proton Therapy Offer Demonstrable Clinical Advantages for Treating Thoracic Tumors?☆Zhongxing Liao, Saumil J Gandhi, Steven H Lin, ScienceDirect
Authored Content
- Cost Analysis of PET/CT vs. CT as Surveillance for Stage III Non-Small Cell Lung Cancer After Definitive Radiation TherapyMarch 2018
- Out of the Darkness and into the Light: New Strategies for Improving Treatments for Locally Advanced Non-Small Cell Lung CancerFebruary 2018
Press Mentions
Nanobiotix Announces First Data from the Completed Dose Escalation Part of a Phase 1 Study Evaluating NBTXR3 (JNJ-1900) as a 2L+ Therapy for Patients with Locally Advanced NSCLCMarch 27th, 2025
Leading Radiation Oncologist Zhongxing Liao, MD, Is to Be Recognized as a 2016 Top Doctor in Houston, TexasJanuary 9th, 2017
Grant Support
- Risk prediction and longitudinal assessment of cardiotoxicity and functional capacity trajectory in NSCLC patientsUNIVERSITY OF TX MD ANDERSON CAN CTR2021–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: